Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG – Research Report), Pharvaris (PHVS – Research Report) and Stevanato Group (STVN –...
Kepler Capital analyst Christophe dombu maintained a Sell rating on Galapagos on October 2 and set a price target of €23.50. The company’s shares closed last Thursday at €30.50.Elevate Your Investing...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...
The company expects to announce a new CFO “in the coming months.”
The Belgium-based biotech company said it would reduce its workforce by 40%, eliminating about 300 positions across Europe.
/PRNewswire/ -- The Lausanne-based team of US investment firm, +ND Capital, today marked its second successful exit in the European biotechnology market as...